RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Renovaro Biosciences Inc. ("Renovaro" or the "Company") (NASDAQ: RENB) on behalf of Renovaro stockholders.
- NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Renovaro Biosciences Inc. ("Renovaro" or the "Company") (NASDAQ: RENB) on behalf of Renovaro stockholders.
- Our investigation concerns whether Renovaro has violated the federal securities laws and/or engaged in other unlawful business practices.
- Click here to participate in the action.
- Following publication of the Hindenburg report, Renovaro's stock price fell $1.44 per share, or 42.86%, to close at $1.92 per share on February 13, 2024, damaging investors.